Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Setnikar I., Cereda R., Pacine M.A., Revel L. (1991) Antireactive properties of glucosamine sulfate. Arzneim.-Forsch/Drug Res. 41:157-161.
Jimenez S.A., Dodge G.R. (1997) The effects of glucosamine sulfate (GS04) on human chondrocyte gene expression. Osteoarthritis and Cartilage 5(SA):72.
Dodge G.R., Hawkins J.F., Jimenez S.A. (1999) Modulation of aggrecan MMPI and MMP3 productions by glucosamine sulfate in cultured human osteoarthritis articular chondrocytes. Arthritis Rheum 42 S:253.
Basleer C., Rovati L., Franchimont P. (1998) Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritis articular cartilage in vitro. Osteoarthritis Cartilage 6:427-434.
Sandy J.D., Gamett D., Thompson V., Verscharen C. (1998) Chondrocyte-mediated catabolism of aggrecan: Aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. Biochem. J 355:59-66.
Shikhman A., Alaaeddine N., Lotz La Jolla M.K. (1991) N-acetylglucosamine prevents IL-1 mediated activation of chondrocytes. Arthrites Rheum. 42 S:381.
Abelda S.M., Buck C.A. (1990) Integrins and other cell adhesion molecules. FASEB J 4:2868-2880.
Piperno M., Reboul P., Hellio Le Graverand M.E., Peschard M.J., Annefeld M., Richard M., Vignon E. Osteoarthritis Cartilage 1998, 6:393-399.
Conrozier T., Mathieu P., Piperno M., Richard S., Annefeld M., Richard M., Vignon E. (1998) Glucosamine sulfate significantly reduced cartilage destruction in a rabbit model of osteoarthritis. Arthritis Rheum. 415:147.
Reichelt A., Forster K.K., Fischer M., Rovati L.C., Setnikar I. (1994) Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. Arzneimittel/Forschung Drug Research 44:175-180.
Setnikar I., Palumbo R., Canali S., Zanolo G. (1993) Pharmacokinetics of glucosamine in man. Arzneimittel/Forschung Drug Research 43:10.
Noack W., Fischer M., Forster K.K., Rovati L.C., Setnikar I. (1994) Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis and Cartilage 2:51-59.
Rovati L.C. (1997) Clinical development of glucosamine sulfate as selective drug in osteoarthritis. Rheumatology in Europe 26(SUPPL. 2):70.
Houpt J.B., McMillan R., Wein C., Paget-Dellio S.D. (1999) Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. Journal of Rheumatology 26:11.
Rovati L.C. (1993) Clinical efficacy of glucosamine sulfate in osteoarthritis of the spine. Rev. Esp. Reumatol. 20(SUPPL. 1):325.
Fassbender H.M., Bach G.L., Haase W., Rovati L.C., Setnikar I. (1994) Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis and Cartilage 2:61-69.
Qiu G.X., Gao S.N., Giacovelli G., Rovati L., Setnikar I. (1998) Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis. Arzneimittel/Forschung Drug Research 48(5):469-474.
Rovati L.C. (1997) The clinical profile of glucosamine sulfate as a selective symptom modifying drug in osteoarthritis: Current data and perspectives. Osteoarthritis Cart 5(SA):72.
Reginster J.Y., Deroisy R., Paul I., Lee R.L., Henrotin Y., Giacovelli G., Dacre J., Rovati L.C., Gosset C. (1999) Glucosamine sulfate significantly reduces progression of knee osteoarthritis over 3 years: A large, randomised, placebo-controlled, double-blind, prospective trial. Arthritis and Rheumatism 42(SUPPL. 9):400.
Towheed T.E., Anastassiades T.P. (1999) Glucosamine therapy for osteoarthritis. Journal of Rheumatology 26:11.
Tapadinhas M.J., Rivera I.C., Bignamini A.A. (1982) Oral glucosamine sulphate in the management of arthrosis report on a multi-centre open investigation in Portugal. Pharmacotherapeutica 3:157-168.
Adams M.E. (1999) Hype about glucosamine. Lancet 354:353-354.
Rovati L.C., Annefeld M., Giacovelli G., Schmid K., Setnikar I., Cumming A., Russell A.I., Mc Carthy M.F. (1999) Glucosamine in osteoarthritis. Lancet 4:1640.
